Alport Syndrome Pipeline Analysis 2019 (H1)
Alport Syndrome Pipeline Analysis report covers more than 5 drugs currently in different phases of development. Alport Syndrome is an inherited disorder...
Autoimmune Hepatitis Pipeline Analysis 2018 | Industry Report | Forecasts till 2024
Autoimmune Hepatitis Pipeline Analysis report covers drugs of 7 companies currently in different phases of development. Autoimmune hepatitis is a long-lasting...
Cachexia Pipeline Analysis 2018 | Industry Report | Forecasts till 2024
Cachexia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Cachexia Pipeline...
Choroideremia Pipeline Analysis 2019 (H1)
Choroideremia Pipeline Analysis report covers 5 drugs currently in different phases of development. Choroideremia is a rare inherited disorder characterized...
Clostridium Difficile infections Pipeline Analysis 2018 | Industry Report | Forecasts till 2024
Clostridium Difficile infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other...
Congenital Afibrinogenemia Pipeline Analysis 2019 (H1)
Congenital afibrinogenemia Pipeline Analysis report covers drugs of 2 companies currently in different phases of development. Congenital afibrinogenemia...
Hypoparathyroidism Pipeline Analysis 2019 (H1)
Hypoparathyroidism Pipeline Analysis report covers 5 drugs currently in different phases of development. Hypoparathyroidism is a rare condition that...
Myasthenia Gravis Pipeline Analysis 2018 | Industry Report | Forecasts till 2024
Myasthenia Gravis Pipeline Analysis report covers 17 drugs currently in different phases of development. Myasthenia gravis (MG) is a neuromuscular disorder...
Myelodysplastic Syndrome (MDS) Pipeline Analysis 2018 | Industry Report | Forecasts till 2024
Myelodysplastic Syndromes (MDS) are conditions that can occur when the blood cells in the bone marrow become abnormal. It is considered as a type of cancer....
Myelofibrosis (MF) Pipeline Analysis 2019 (H1)
Myelofibrosis Pipeline Analysis report 2019 (H1) covers more than 10 drugs currently in different phases of development. Myelofibrosis is a chronic...